Related Experiment Video
Updated: Dec 31, 2025

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Transforming growth factor beta (TGF-β) is activated by the CtBP2-p300-AP1 transcriptional complex in chronic renal
Ping Zhou1, Xiaoxiao Wan1, Yan Zou1
1Department of Nephrology, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang 330006, Jiangxi, China.
Abstract:
Chronic renal failure (CRF), also known as chronic kidney disease (CKD), is a common renal disorder characterized by gradual kidney dysfunction. Molecular dissection reveals that transforming growth factor beta (TGF-β) plays a central role in the pathogenesis of CRF. However, the mechanism underlying TGF-β upregulation has not been demonstrated. Here, we verified that the elevated level of TGF-β was associated with the severity of CRF stages and the activation of TGF-β-mediated signaling in 120 renal biopsies from CRF patients. By analyzing the promoter region of the TGFB1 gene, we identified one AP-1 (activator protein 1) and four NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) binding sites. Knockdown of two AP-1 subunits (c-Jun and c-FOS) or blockage of AP-1 signaling with two inhibitors T-5224 and SR11302 could cause the downregulation of TGFB1, whereas knockdown of two NF-κB subunits (p65 and p50) or blockage of NF-κB signaling with two inhibitors TPCA1 and BOT-64 could not change the expression of TGFB1. Using mass spectrometry and coimmunoprecipitation analyses, we found that both c-Jun and c-FOS formed a complex with CtBP2 (C-terminal binding protein 2) and histone acetyltransferase p300. Our in vitro data demonstrated that induction of CtBP2 by recombinant IL-1β (interleukin-1 beta) led to the upregulation of TGFB1 and the activation of TGF-β downstream signaling, while knockdown of CtBP2 resulted in the reversed effects. Using chromatin immunoprecipitation assays, we revealed that the CtBP2-p300-AP1 complex specifically bound to the promoter of TGFB and that knockdown or blockage of CtBP2 significantly decreased the occupancies of the p300 and AP-1 subunits. Our results support a model in which the CtBP2-p300-AP1 transcriptional complex activates the expression of TGFB1, increasing its production and extracellular secretion. The secreted TGF-β binds to its receptors and initiates downstream signaling.
Insights
Transforming growth factor beta (TGF-β) drives chronic kidney disease progression. A novel CtBP2-p300-AP1 complex upregulates TGFB1, revealing a key mechanism in chronic renal failure.
Area of Science:
- Nephrology
- Molecular Biology
- Biochemistry
Background:
- Chronic renal failure (CRF), or chronic kidney disease (CKD), is a progressive decline in kidney function.
- Transforming growth factor beta (TGF-β) is implicated in CRF pathogenesis, but its upregulation mechanism remains unclear.
Purpose of the Study:
- To elucidate the molecular mechanism driving TGF-β upregulation in chronic renal failure.
- To investigate the role of transcription factors and co-regulators in TGFB1 gene expression.
Main Methods:
- Analysis of renal biopsies from CRF patients.
- Gene expression analysis, including promoter region identification (AP-1, NF-κB binding sites).
- Protein-protein interaction studies (mass spectrometry, coimmunoprecipitation), gene knockdown, and chromatin immunoprecipitation assays.
Main Results:
- Elevated TGF-β levels correlate with CRF severity.
- AP-1 (c-Jun, c-Fos) subunits, not NF-κB, regulate TGFB1 expression.
- A CtBP2-p300-AP1 complex binds the TGFB1 promoter, driving gene expression and TGF-β signaling.
Conclusions:
- The CtBP2-p300-AP1 complex is a key regulator of TGFB1 in CRF.
- This finding offers a potential therapeutic target for managing chronic kidney disease progression.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
11:47Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
Related Concept Videos
TGF - β Signaling Pathway
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Master Transcription Regulators
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...